Fasiglifem，TAK-875

Ingoa matū:

(S)-2-(6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3 -dihydrobenzofuran-3-yl)acetic acid

Waehere SMILES:

O=C(O)C[C@@H]1COC2=CC(OCC3=CC(C4=C(C)C=C(OCCCS(=O)(C)=O)C=C4C)=CC=C3 )=CC=C12

Waehere InChi:

InChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21( 14-22)17-35-24-8-9-2 6-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2, 1-3H3,(H,30,31)/t23-/m1/s1

Kī InChi:

BZCALJIHZVNMGJ-HSZRJFAPSA-N

Kupumatua:

1000413-72-8；CAS:1000413-72-8；CAS:1000413-72-8；TAK875；TAK-875；TAK 875；Fasiglifam

Wairewa:Wairewa ki DMSO, kaua ki te wai

Rokiroki:0 - 4 C mo te wa poto (ra ki nga wiki), -20 C ranei mo te wa roa (marama).

Whakaahuatanga:

Ko te Fasiglifam (TAK-875) he agonist GPR40 whai hua, waha, me te whiriwhiri.

Whainga: GPR40 agonist